Abstract:Nicotinamide adenine dinucleotide (NAD + ), a coenzyme for more than 500 enzymes, plays a central role in energy production, metabolism, cellular signaling, and DNA repair. Until recently, NAD + was primarily considered to be an intracellular molecule (iNAD + ), however, its extracellular species (eNAD + ) has recently been discovered and has since been associated with a multitude of pathological conditions. Therefore, accurate quantification of eNAD + in bodily fluids such as plasma is paramount to answer important research questions. In order to create a clinically meaningful and reliable quantitation method, we analyzed the relationship of cell lysis, routine clinical laboratory parameters, blood collection techniques, and pre-analytical processing steps with measured plasma eNAD + concentrations. Initially, NAD + levels were assessed both intracellularly and extracellularly. Intriguingly, the concentration of eNAD + in plasma was found to be approximately 500 times lower than iNAD + in peripheral blood mononuclear cells (0.253 ± 0.02 μM vs. 131.8 ± 27.4 μM, p = 0.007, respectively). This stark contrast suggests that cellular damage or cell lysis could potentially affect the levels of eNAD + in plasma. However, systemic lactate dehydrogenase in patient plasma, a marker of cell damage, did not significantly correlate with eNAD + ( n = 33; r = −0.397; p = 0.102). Furthermore, eNAD + was negatively correlated with increasing c-reactive protein (CRP, n = 33; r = −0.451; p = 0.020), while eNAD + was positively correlated with increasing hemoglobin ( n = 33; r = 0.482; p = 0.005). Next, variations in blood drawing, sample handling and pre-analytical processes were examined. Sample storage durations at 4°C (0–120 min), temperature (0° to 25°C), cannula sizes for blood collection and tourniquet times (0 – 120 s) had no statistically significant effect on eNAD + ( p > 0.05). On the other hand, prolonged centrifugation (> 5 min) and a faster braking mode of the centrifuge rotor (< 4 min) resulted in a significant decrease in eNAD + levels ( p < 0.05). Taken together, CRP and hemoglobin appeared to be mildly correlated with eNAD + levels whereas cell damage was not correlated significantly to eNAD + levels. The blood drawing trial did not show any influence on eNAD + , in contrast, the preanalytical steps need to be standardized for accurate eNAD + measurement. This work paves the way towards robust eNAD + measurements, for use in future clinical and translational research, and provides an optimized hands-on protocol for reliable eNAD + quantification in plasma.

Fingerstick blood assay maps real‐world NAD+ disparity across gender and age

Nicotinamide Effects on the Metabolism of Human Fibroblasts and Keratinocytes Assessed by Quantitative, Label-Free Fluorescence Imaging

NADomics: Measuring NAD+ and Related Metabolites Using Liquid Chromatography Mass Spectrometry

Association of Human Whole Blood NAD+ Contents With Aging

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Illuminating NAD+ Metabolism in Live Cells and in Vivo Using a Genetically Encoded Fluorescent Sensor.

Spatiotemporal monitoring of NAD+ metabolism with fluorescent biosensors

Ratiometric NAD + Sensors Reveal Subcellular NAD + Modulators

Real-time assessment of the metabolic profile of living cells with genetically encoded NADH sensors.

Towards personalized nicotinamide mononucleotide (NMN) supplementation: nicotinamide adenine dinucleotide (NAD) concentration

Quantitative dynamics of intracellular NMN by genetically encoded biosensor

Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational research

The nanomolar sensing of nicotinamide adenine dinucleotide in human plasma using a cycling assay in albumin modified simulated body fluids

Development and Validation of an LC-MS/MS Method for Quantifying NAD + and Related Metabolites in Mice Sciatic Nerves and Its Application to a Nerve Injury Animal Model

Absolute quantification of nicotinamide mononucleotide in biological samples by double isotope-mediated liquid chromatography-tandem mass spectrometry (dimeLC-MS/MS)

Molecular beacon based bioassay for highly sensitive and selective detection of nicotinamide adenine dinucleotide and the activity of alanine aminotransferase.

Association of NAD+ levels with metabolic disease in a community-based study

Genetically encoded biosensors for evaluating NAD+/NADH ratio in cytosolic and mitochondrial compartments

Plasma NAD(H) Measurement to Monitor Brain Pathophysiology

A Luminescent-Based Protocol for NAD+/NADH Detection in C. Elegans, Mice, and Human Whole Blood